Outcomes of hypofractionated stereotactic body radiotherapy boost for intermediate and high-risk prostate cancer

BACKGROUND AND PURPOSE: Treatment of intermediate and high-risk prostate cancer with a high BED has been shown to increase recurrence free survival (RFS). While high dose rate (HDR) brachytherapy, given as a boost is effective in delivering a high BED, many patients are not candidates for the proced...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Radiat Oncol
Autori principali: Anwar, Mekhail, Weinberg, Vivian, Seymour, Zachary, Hsu, I. Joe, Roach, Mack, Gottschalk, Alex R.
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2016
Soggetti:
Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4721063/
https://ncbi.nlm.nih.gov/pubmed/26792201
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13014-016-0585-y
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi